Live: Will Oklo Smash Q1 Earnings Tonight?

That wraps up our initial coverage of Oklo’s Q1 results. Thank you for stopping by!

Check out management’s earnings call at 5 PM EST for more updates.

Oklo (NYSE:OKLO | OKLO Price Prediction) insiders have been net sellers over the past 3 months.

Activity skews overwhelmingly toward selling, with roughly 178 sales and zero open-market purchases across the past six months.

Co-founders DeWitte and Cochran have each unloaded 200,000 shares monthly under 10b5-1 plans adopted March 31, 2025. CFO Bealmear, CTO Schweiger, and CLO Goodwin also trimmed; directors Peters, Kan, Park, and Christian received RSU grants April 10.

Pre-planned cadence softens the signal, yet insiders are choosing to monetize the run-up rather than buy more.

With Q1 results now public, here are the Bull and Bear cases for Oklo:

Bull Case

• Liquidity sits at $2.5B, fully funding the Aurora-INL build and removing dilution risk through commercial deployment.
• NRC just accelerated Aurora’s Principal Design Criteria approval, the clearest licensing signal yet for the late 2027 startup.
• Atomic Alchemy isotope revenue is still tracked for 2026, giving Oklo a path to its first dollar of sales.
• Shares are up 178.14% over one year on hyperscaler power demand.

Bear Case

• Q1 adjusted EPS of -$0.19 missed the -$0.18 consensus, and revenue remains zero.
• Investing outflows hit $359.0M in the quarter, a steep capital intensity ramp.
• Market cap near $12.8B bakes in flawless execution through 2028.
• Customer agreements remain largely non-binding LOIs.

What Moves Oklo From Here

With Q1 results out, attention shifts to the next set of catalysts that will determine whether Oklo’s recent 55.48% one-month rally holds.

• Groves criticality: Management reaffirmed a July 4, 2026 target, with first Atomic Alchemy revenue expected this year.
• Aurora-INL construction: Watch for the Preliminary Documented Safety Analysis and updated CapEx disclosure later in 2026, ahead of 2028 nuclear heat production.
• Customer conversions: Binding contracts beyond the 1.2 gigawatt Meta agreement, plus military and oil & gas pipeline.
• NRC pathway: Tennessee recycling facility readiness review and any guidance on DOE-to-NRC conversion process.
• Q2 earnings (August 2026): Cash burn against the $80 million to $100 million operating guide.

The average analyst price target sits at $91.36, with 15 buy ratings outweighing 5 hold calls. Execution on Groves and Aurora milestones will decide whether that gap closes.

Oklo reported Q1 adjusted EPS of -$0.19 versus estimates of -$0.18, while again reporting no commercial revenue as Aurora remains pre-operational.

The bigger development came earlier this week when the NRC accelerated approval of Aurora’s Principal Design Criteria, a key licensing milestone that helps establish safety and performance standards for future deployment.

Investors remain focused on whether Oklo can reach commercial operation before needing additional large capital raises, especially as AI-driven hyperscaler power demand continues accelerating.

Oklo just reported earnings. Here are the key numbers:

• Adj. EPS: -$0.18 vs. -$0.18 expected
• Net loss: $33.1M
• Cash used in operating activities: $17.9M
• Cash used in investing activities: $359.0M
• Cash & marketable securities: $2.5B

Quick read:

• Oklo’s cash position climbed to $2.5B following its ATM offering, removing a major financing overhang
• The company continues expanding its vertically integrated nuclear platform across power generation, fuel recycling, and isotope production

Management also highlighted growing demand from data center, utility, industrial, and oil & gas customers.

Shares are initially down 3% following the report.

Bull Case

• Customer pipeline expanded to ~14 GW, anchored by the Meta (NASDAQ:META) prepayment supporting up to 1.2 gigawatts in Pike County, Ohio.
• $2.6 billion in total liquidity removes near-term financing risk.
• Groves reactor targeting criticality by July 4, 2026, with first isotope revenue expected this year.
• Sentiment surged on the NVIDIA (NASDAQ:NVDA) partnership and recent NRC design approval.

Bear Case

• Still pre-revenue; FY2025 operating loss reached $139.3 million.
• 2026 cash burn is guided higher at $80 million to $100 million, plus $350 million to $450 million in investing outflows.
• Shares ran 55.48% in one month, raising valuation risk on any soft commentary.
• Polymarket resolved “No” last quarter, a reminder that estimates can slip.

Analysts’ average price target is currently $91.36, while the stock trades around $73.56.

Oklo’s last earnings report largely removed financing concerns around the business. The company exited 2025 with roughly $1.4 billion in cash and marketable securities, then added another $1.18 billion through its ATM program in January. Total liquidity now sits near $2.5 billion, versus expected 2026 cash burn of just $80 million to $100 million.

Regulatory progress also accelerated in March, with DOE approval for the Aurora-INL Nuclear Safety Design Agreement and an NRC materials license for Oklo’s Atomic Alchemy subsidiary. Management expects Atomic Alchemy to generate its first revenue in 2026.

Oklo continues standing out in the SMR (small modular reactors) space because of its business model.

Most SMR companies sell reactors to customers, while Oklo plans to own and operate reactors itself and sell electricity directly through long-term agreements. That gives Oklo exposure to recurring power revenue instead of one-time equipment sales.

The global SMR offtake pipeline has climbed to roughly 45 GW as hyperscalers race to secure future AI power capacity. Oklo is also using the DOE Reactor Pilot Program for parts of its licensing process, which could help accelerate deployment timelines relative to peers.

Oklo’s Q4 earnings tonight could become a major catalyst for the stock.

Shares trade near $74, down roughly 50% from the stock’s October 2025 high near $174, despite continued progress across commercial agreements and nuclear demand trends. Meta signed a 1.2 GW power agreement with Oklo in January, while EPRI now projects data centers could consume 9-17% of U.S. electricity by 2030.

The market’s hesitation comes down to timing, with Oklo not expected to deliver its first power until 2027. Investors will now look for updates on Aurora-INL, the July 2026 criticality target, and the long-rumored OpenAI partnership.

Oklo (NYSE:OKLO) reports at 4 PM ET after the bell tonight.

Top 5 Analyst Questions

• Is the 14 GW pipeline converting from non-binding LOIs into binding PPAs?
• Timing of the NRC combined license application (COLA) submission?
• Did Atomic Alchemy generate any 2026 radioisotope revenue?
• Cash burn trajectory versus the prior $275.30M liquidity position?
• Updates on HALEU sourcing and the Lightbridge recycling collaboration?

Key Topics

• Idaho National Laboratory site readiness for late 2027 deployment
• Equinix 500 MW LOI and Switch 12 GW agreement progression
• Aurora powerhouse scaling to 75 MW

Red Flags

• Slippage in COLA timing or first deployment past early 2028
• Equity raise signaling or accelerating burn
• Customer attrition from the 2,100 MW-to-14 GW pipeline

Analysts’ average price target sits at $91.36, with shares down 5.93% today to $73.83.

This Quarter Could Reset the Narrative

Oklo shares are up 178% over the past year as investors increasingly price in a credible path toward commercial advanced nuclear deployment. The company now has NRC Principal Design Criteria approval in hand, a growing customer pipeline, and strategic relationships tied to rising AI-driven power demand.

This quarter matters because the focus shifts from regulatory progress toward commercial execution.

Investors want to see whether Atomic Alchemy begins contributing early radioisotope revenue, whether the Aurora licensing timeline continues to support targeted 2027 to 2028 deployment, and whether operating cash burn remains controlled as development activity ramps up.

If management delivers measurable progress across commercialization, licensing, and deployment readiness, Oklo’s long-term thesis will strengthen materially.